Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Colorectal Neoplasms × Radiotherapy × Clear all

Phase

Status

Completed 27 Unknown 9 Terminated 5 Active not recruiting 5 Withdrawn 4 Recruiting 4 Not yet recruiting 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Injuries 1 Oropharyngeal Neoplasms 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Oxaliplatin 2 Bevacizumab 2 vactosertib 1 titanium silicide 1 regorafenib 1 obeticholic acid 1 fludarabine phosphate 1 balstilimab 1 apatinib 1 aldesleukin 1 Specimen Handling 1 S 1 (combination) 1 Riluzole 1 Radiotherapy 1 Radiosurgery 1 Maintenance 1 Leucovorin 1 Irinotecan 1 Interleukin-2 1 IL32 protein, human 1 Hepatectomy 1 Fluorouracil 1 Flavonoids 1 Endoscopy, Gastrointestinal 1 Cyclophosphamide 1 Colonoscopy 1 Capecitabine 1 Biopsy 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02121405 2022-05-11

PSSR

Zhejiang University

Phase 3 Suspended

Gastrointestinal

Radiation Injuries, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡